Clinical Trial Update: Regression of Cervical Precancerous Lesions and Associated Risk Factors

View source ↗

Summary

A Prague-based clinical trial is currently recruiting to study regression of cervical precancerous lesions and associated risk factors, focusing on CIN2/3 and H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Snippet

Sponsor: General University Hospital, Prague | Conditions: Cervix Uteri SIL, HPV | Status: RECRUITING